UnitedHealth Is Targeting 13% to 16% Long-Term Earnings Growth. Where Will the Stock Be in 5 Years?
Key PointsUnitedHealth’s third-quarter earnings from operations rose, and management raised its 2026 adjusted earnings outlook.
UnitedHealth Group (UNH) has set ambitious long-term growth targets for its earnings, aiming for 13% to 16% growth, which it reiterated during its Oct. 13 earnings call. With its turnaround strategy gaining traction and Optum expanding growth opportunities, potential upside for UNH shares by 2031 could be substantial. Currently, the company trades at a forward price-to-earnings (P/E) ratio of around 17.
If UnitedHealth can deliver on its earnings growth targets, its stock could see significant gains over the next five years. Optimistic projections using base case growth assumptions could see earnings per share (EPS) reach $37.77 by 2031, implying a potential stock price of $699, or a 71.5% increase. Conservative projections under the same base case could lift EPS to $30.12 by 2031, suggesting a potential upside of 3.5%.
However, the stock could achieve even higher valuations, with a bull case suggesting a P/E ratio of 22 times, pushing the target price to $947 and implying a potential upside of 132.4%. Factors such as Optum's expanding healthcare services, AI-driven productivity gains, and Medicare Advantage earnings recovery could justify higher valuations.
While these scenarios are not guarantees, they highlight the potential for UnitedHealth to offer a higher valuation compared to traditional health insurers.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.